- Signature of arylacetamide deacetylase expression is associated with prognosis and immune infiltration in ovarian cancer
-
Feng J, He H
- KMID: 2524685
- Obstet Gynecol Sci.
- 2022 Jan;65(1):52-63.
- doi: 10.5468/ogs.21237
Objective The role of the protein-coding gene arylacetamide deacetylase (AADAC) in the prognostication of ovarian cancer remains uncertain. We aimed to identify and validate its prognostic value using integrated bioinformatics analyses. Methods Gene... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer
-
Angeles MA, Cabarrou B, Gil-Moreno A, Pérez-Benavente A, Spagnolo E, Rychlik A, Martínez-Gómez C, Guyon F, Zapardiel I, Querleu D, Illac C, Migliorelli F, Bétrian S, Ferron G, Hernández A, Martinez A
- KMID: 2526273
- J Gynecol Oncol.
- 2021 Nov;32(6):e78.
- doi: 10.3802/jgo.2021.32.e78
Objective We sought to evaluate the impact on survival of tumor burden and surgical complexity in relation to the number of cycles of neoadjuvant chemotherapy (NACT) in patients with advanced ovarian... -
- CITED
-
- Close
- SHARE
-
- Close
- Adnexal Masses: Clinical Application of Multiparametric MR Imaging & O-RADS MRI
-
Eom SY, Rha SE
- KMID: 2520683
- J Korean Soc Radiol.
- 2021 Sep;82(5):1066-1082.
- doi: 10.3348/jksr.2021.0111
Incidental adnexal masses considered indeterminate for malignancy are commonly observed on ultrasonography. Multiparametric MRI is the imaging modality of choice for the evaluation of sonographically indeterminate adnexal masses. Conventional MRI... -
- CITED
-
- Close
- SHARE
-
- Close
- The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
-
Ha HI, Chang HK, Park SJ, Lim J, Won YJ, Lim MC
- KMID: 2520264
- Obstet Gynecol Sci.
- 2021 Sep;64(5):444-453.
- doi: 10.5468/ogs.21116
Objective The three major gynecologic cancers are cervical, endometrial, and ovarian cancer. This study aimed to describe the 19-year trends and survival rates in cervical, endometrial, and ovarian cancer in... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study
-
Park JY, Lim MC, Baek MH, Park YH, Kim S
- KMID: 2526122
- J Gynecol Oncol.
- 2021 Jul;32(4):e65.
- doi: 10.3802/jgo.2021.32.e65
Objective Investigation of new drugs (INDs) is a tremendously inefficient process in terms of time and cost. Drug repositioning is another method used to investigate potential new agents in well-known drugs.... -
- CITED
-
- Close
- SHARE
-
- Close
- Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells
-
Cho Hy, Kim YB, Park Wh, No JH
- KMID: 2518406
- Cancer Res Treat.
- 2021 Jul;53(3):819-828.
- doi: 10.4143/crt.2020.1013
Purpose This study aimed to evaluate anticancer effects of combination treatment with poly(ADP-ribose) polymerase (PARP) and checkpoint kinase 1 (Chk1) inhibitors in BRCA wild-type ovarian cancer. PARP inhibitors can function... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Umbilical Metastasis (Sister Mary Joseph’s Nodule) from Mucinous Ovarian Carcinoma
-
Kang MJ, Seo JM, Yun SY, Lee JH, Yu DS, Lee YB
- KMID: 2517151
- Korean J Dermatol.
- 2021 Jun;59(5):413-415.
-
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of different NEoplasias in the adneXa model for differentiation of benign and malignant adnexal masses in Korean women
-
Nam G, Lee SR, Jeong K, Kim SH, Moon HS, Chae HD
- KMID: 2515981
- Obstet Gynecol Sci.
- 2021 May;64(3):293-299.
- doi: 10.5468/ogs.21012
Objective Ultrasonographic differential diagnosis of ovarian tumors is important for appropriate management. We conducted study to compare the performance of the Assessment of Different NEoplasias in the adneXa (ADNEX) model... -
- CITED
-
- Close
- SHARE
-
- Close
- Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
-
Ha HI, Lee EG, Lim J, Jung SY, Chang YJ, Won YJ, Lim MC
- KMID: 2514934
- Cancer Res Treat.
- 2021 Apr;53(2):541-548.
- doi: 10.4143/crt.2020.1001
Purpose A prior history of breast cancer is a risk factor for the subsequent development of primary peritoneal, epithelial ovarian, and fallopian tubal (POFT) cancers. This study aimed to estimate... -
- CITED
-
- Close
- SHARE
-
- Close
- The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
-
Tokunaga H, Mikami M, Nagase S, Kobayashi Y, Tabata T, Kaneuchi M, Satoh T, Hirashima Y, Matsumura N, Yokoyama Y, Kawana K, Kyo S, Aoki D, Katabuchi H
- KMID: 2526387
- J Gynecol Oncol.
- 2021 Mar;32(2):e49.
- doi: 10.3802/jgo.2021.32.e49
The fifth edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer was published in 2020. The guidelines... -
- CITED
-
- Close
- SHARE
-
- Close
- A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
-
Lee YJ, Lim MC, Kim BG, Ngoi NY, Choi CH, Park SY, Tan DS, Go Y, Lee JY
- KMID: 2526377
- J Gynecol Oncol.
- 2021 Mar;32(2):e31.
- doi: 10.3802/jgo.2021.32.e31
Background: The optimal treatment of BRCA wild-type patients with platinum-sensitive recurrent ovarian cancer remains unknown. Recently, there is an increase in the evidence to support the role of the combination... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
-
Tan DS, Chan JJ, Hettle R, Ghosh W, Viswambaram A, Yu CC
- KMID: 2526375
- J Gynecol Oncol.
- 2021 Mar;32(2):e27.
- doi: 10.3802/jgo.2021.32.e27
Objective: To evaluate the cost-effectiveness of olaparib as a maintenance treatment versus routine surveillance (RS) in patients with BRCA mutated (BRCAm) advanced ovarian cancer (OC) following response to first-line platinum-based... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
-
Motohashi T, Yabuno A, Michimae H, Ohishi T, Nonaka M, Takano M, Nishio S, Fujiwara H, Keiichi K, Kondo E, Sugiyama T, Tabata T
- KMID: 2526299
- J Gynecol Oncol.
- 2021 Jan;32(1):e9.
- doi: 10.3802/jgo.2021.32.e9
Objective: The standard dose for pegylated liposomal doxorubicin (PLD) is 50 mg/m2 every 4 weeks. While 40 mg/m2 has recently been used in clinical practice, evidence supporting this use remains... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility and safety of fertilitysparing surgery in epithelial ovarian cancer with dense adhesion: a longterm result from a single institution
-
Baek MH, Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT
- KMID: 2512054
- J Gynecol Oncol.
- 2020 Nov;31(6):e85.
- doi: 10.3802/jgo.2020.31.e85
Objective: We investigated the feasibility and safety of fertility-sparing surgery (FSS) in patients with epithelial ovarian cancer (EOC) with dense adhesions. Methods: Patients were divided into cases with and without dense... -
- CITED
-
- Close
- SHARE
-
- Close
- Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
-
Ha HI, Ryu JS, Shim H, Kong SY, Lim MC
- KMID: 2512052
- J Gynecol Oncol.
- 2020 Nov;31(6):e83.
- doi: 10.3802/jgo.2020.31.e83
Objective: We investigated the proportions of and reclassified BRCA1/2 variants of unknown significance (VUS) in Korean patients with epithelial ovarian, tubal, and primary peritoneal cancers. Methods: Data from 805 patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
-
Kim SI, Lee M, Kim HS, Chung HH, Kim JW, Park NH, Song YS
- KMID: 2507948
- Cancer Res Treat.
- 2020 Oct;52(4):1229-1241.
- doi: 10.4143/crt.2020.557
Purpose This study aimed to present a single institutional experience with BRCA1/2 gene tests and the effects of pathogenic mutations in epithelial peritoneal, ovarian, and fallopian tube cancer (POFTC) on survival... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
-
Ogasawara A, Hihara T, Shintani D, Yabuno A, Ikeda Y, Tai K, Fujiwara K, Watanabe K, Hasegawa K
- KMID: 2507947
- Cancer Res Treat.
- 2020 Oct;52(4):1219-1228.
- doi: 10.4143/crt.2019.688
Purpose Circulating tumor DNA (ctDNA) is an attractive source for liquid biopsy to understand molecular phenotypes of a tumor non-invasively, which is also expected to be both a diagnostic and prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
-
Chung YS, Kim HS, Lee JY, Kang WJ, Nam EJ, Kim S, Kim SW, Kim YT
- KMID: 2507946
- Cancer Res Treat.
- 2020 Oct;52(4):1211-1218.
- doi: 10.4143/crt.2019.506
Purpose The aim of this study was to evaluate the ability of sequential 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) after one cycle of neoadjuvant chemotherapy (NAC) to predict chemotherapy response before... -
- CITED
-
- Close
- SHARE
-
- Close
- Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis
-
Chiyoda T, Sakurai M, Satoh T, Nagase S, Mikami M, Katabuchi H, Aoki D
- KMID: 2511979
- J Gynecol Oncol.
- 2020 Sep;31(5):e67.
- doi: 10.3802/jgo.2020.31.e67
Objective: To assess the effectiveness of lymphadenectomy at primary debulking surgery (PDS) on the survival of patients with epithelial ovarian cancer (EOC). Methods: We searched PubMed, Ichushi, and the Cochrane Library.... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands
-
Burg L, Timmermans M, van der Aa M, Boll D, Rovers K, Hingh Id, Altena Av
- KMID: 2511972
- J Gynecol Oncol.
- 2020 Sep;31(5):e58.
- doi: 10.3802/jgo.2020.31.e58
Objective: Peritoneal metastases (PM) are a challenge in gynecological cancers, but its appearance has never been described in a population-based study. Therefore, we describe the incidence of PM and identify... -
- CITED
-
- Close
- SHARE
-
- Close
